An American Brain Tumor Consortium (ABTC) Phase 1 Trial of Veliparib (ABT-888), Temozolomide (TMZ), and Concurrent Radiation Therapy (RT) for Newly Diagnosed Glioblastoma Multiforme (GBM): Need for Modification to Approach for Combining These Therapies

Phase 1 TITE-CRM Dose Escalation Study of Concurrent Temozolomide and Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.298 ◽

2009 ◽

Vol 75 (3) ◽

pp. S124 ◽

Cited By ~ 1

Author(s):

D.R. Brown ◽

D. Normolle ◽

L.R. Junck ◽

T.S. Lawrence ◽

J.A. Heth ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Dose Escalation ◽

Phase 1 ◽

Intensity Modulated Radiation Therapy ◽

Newly Diagnosed ◽

Dose Escalation Study ◽

Intensity Modulated ◽

Initial Results of a Phase 1/2 Trial on Intraoperative Radiation Therapy (IORT) in Newly Diagnosed Glioblastoma Multiforme (INTRAGO)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.761 ◽

2016 ◽

Vol 96 (2) ◽

pp. E67-E68

Author(s):

F.A. Giordano ◽

S. Brehmer ◽

B. Muerle ◽

G. Welzel ◽

E. Sperk ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase 1 ◽

Intraoperative Radiation Therapy ◽

Newly Diagnosed ◽

Intraoperative Radiation ◽

Initial Results

NCOG-18. PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE

Neuro-Oncology ◽

10.1093/neuonc/nox168.579 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi141-vi142

Author(s):

Ashlee Loughan ◽

Danielle Shafer ◽

Autumn Lanoye ◽

Sarah Braun ◽

Paul Dent ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Dimethyl Fumarate ◽

Newly Diagnosed ◽

Intensification of radiation therapy by temozolomide and fractionated stereotactic boost in newly diagnosed glioblastoma multiforme: A long-term analysis of a phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e12515 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e12515-e12515

Author(s):

G. R. D'Agostino ◽

G. Chiloiro ◽

S. Manfrida ◽

S. Chiesa ◽

G. Apicella ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Term Analysis

A Phase 2 Trial of Hypofractionated–Intensity Modulated Radiation Therapy (Hypo-IMRT) Combined With Temozolomide (TMZ) and Bevacizumab (BEV) for Patients With Newly Diagnosed Glioblastoma Multiforme (GBM)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.05.968 ◽

2014 ◽

Vol 90 (1) ◽

pp. S284-S285

Author(s):

J.A. Carlson ◽

D. Ney ◽

K. Reddy ◽

L.E. Gaspar ◽

B.D. Kavanagh ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Intensity Modulated Radiation Therapy ◽

Phase 2 ◽

Newly Diagnosed ◽

Intensity Modulated ◽

Phase 2 Trial ◽

PDCT-04. PHASE 1 TRIAL OF WEE1 KINASE INHIBITOR AZD1775 COMBINED WITH RADIATION THERAPY FOR CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP PHASE 1 PILOT CONSORTIUM (ADVL1217)

Neuro-Oncology ◽

10.1093/neuonc/noy148.834 ◽

2018 ◽

Vol 20 (suppl_6) ◽

pp. vi201-vi201

Author(s):

Sabine Mueller ◽

Xiaodong Yang ◽

Sharmistha Pal ◽

Ralph Ermioian ◽

Elizabeth Fox ◽

...

Keyword(s):

Radiation Therapy ◽

Kinase Inhibitor ◽

Phase 1 ◽

Diffuse Intrinsic Pontine Glioma ◽

Newly Diagnosed ◽

Oncology Group ◽

Pontine Glioma ◽

Phase 1 Trial ◽

Wee1 Kinase

Erratum to: Kong X-T, Nguyen NT, Choi YJ, et al. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Int J Radiat Oncol Biol Phys 2018;100:1195-1203.

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.01.071 ◽

2019 ◽

Vol 103 (5) ◽

pp. 1289

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Radiat Oncol Biol Phys ◽

Phase 2 ◽

Newly Diagnosed ◽

Safety And Efficacy ◽

Phase 2 Study ◽

Efficacy Assessment

Faculty Opinions recommendation of Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7871956.8220054 ◽

2011 ◽

Author(s):

Marc Chamberlain

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.2023 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 2023-2023 ◽

Cited By ~ 3

Author(s):

J. J. Vredenburgh ◽

A. Desjardins ◽

D. A. Reardon ◽

K. Peters ◽

J. Kirkpatrick ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Newly Diagnosed ◽

Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.2098 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 2098-2098 ◽

Cited By ~ 1

Author(s):

J. J. Vredenburgh ◽

A. Desjardins ◽

D. A. Reardon ◽

K. Peters ◽

J. Kirkpatrick ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Newly Diagnosed ◽

Oral Topotecan